In addition to other resistance mechanisms, using GAB1 and SHP2-GAB1 binding mutants, GAB1 has been shown to be associated with the IL-6-induced dexamethasone resistance mechanism in multiple myeloma cells [138]. The gene discussed is IL6; the disease is plasma cell myeloma.